Unfortunately, that is not the case here, as you will see below. I guess in here, you're reiterating positive EBITDA guidance in the quarter. With half of the year now complete, I'm pleased to say that we just experienced our two best quarters in Tilray's history despite changing industry dynamics and challenges brought on by COVID. The London-based lender supplied billions of dollars in loans to GFG, many of which were packaged and sold onto investors in funds run by Credit Suisse Group AG. (Updates with Alibaba profit details in last paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P. And those improvements were completed in Q1. Market Wrap: Bitcoin Falls for Second Straight Day After Tesla Action; Ether Follows, Bitcoin Miner Argo Blockchain Purchases Hydro-Powered Data Centers in Canada, Jack Ma’s Ant Posted $3.4 Billion Profit After IPO Halt, Alternative Market Sectors That Are Soaring, McDonald’s Gains as It Hikes Wages to Attract Labor, Why McDonald's minimum wage hike is surprisingly good news for the stock, GBP/JPY Price Forecast – British Pound Continues to Work Its Way Higher, Cette belle femme a inspiré 3 chansons populaires. Please go ahead. CVS Health sees 2020 earnings in the range of $7.14 to $7.27 per share, a 13 cent improvement from the top end of the group's prior forecast. It's not necessarily going to be driven by Manitoba Harvest. Hi. If I can have a follow-up there. But what gives you confidence that there's actually adequate supply to supplement that, in particular, given what you're doing with your supply agreements? The inclusion of the medical measure on the ballot in Idaho is uncertain. “Many of our businesses are critical infrastructure assets that are underpinned by long-dated, contracted or regulated cash flows. Tilray missed earnings estimates in the last four quarters, the average negative surprise being 51.31%. And when I look at kind of the sales by potency that we've seen are pretty significant, I guess, growth of sales of higher potency for us in the marketplace to the tune of -- I mean, we're roughly -- in terms of high and mid-potency, we're in the 40% for high potency, 48% for mid-potency and probably 12% in the low potency right now. And so that's a big opportunity for us. Rupesh, I'd just add that we do have a number of 2.0 products in our pipeline that we anticipate launching here in Q3 and into Q4. Tilray last issued its earnings results on February 17th, 2021. Tilray has generated ($1.69) earnings per share over the last year. So just wondering if you can just give a bit more detail as to how you intend to resume growth in that segment because this quarter, it was a sequential decline anyway. Returns as of 05/14/2021. Stock markets in America have been hit rather hard during the trading session as inflation numbers came out stronger than anticipated. 10-Q. Yeah. We also undertook other efforts to increase operating efficiencies, which will result in future additional cost savings. Tilray, Inc.TLRY is scheduled to report second-quarter 2020 results on Aug 10, after market close. Tamy Chen -- BMO Capital Markets -- Analyst. We do not believe we had cut costs or headcount to the extent they will have an adverse impact on our ability to meaningfully grow our business across all categories in 2020 and 2021. This compares to loss of $0.32 per share a year ago. Tilray’s stock has depreciated 52.7% in the year so far compared with the industry’s decline of 4.6%. But I just don't think that it's prudent right now to be giving specific revenue target guidance. Tilray produces medical cannabis in Canada and Europe. Retail sales figures for April will be released on Friday, along with industrial production and consumer sentiment numbers. This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. Real estate stocks have been trading as though no company will ever occupy an office again, no person will ever set foot in a store and nobody will ever travel again, for either business or leisure,” Flatt wrote. Just on the EBITDA target being positive or breakeven by the fourth quarter, what type of sales increase would you need to see to break even? Included in the non-cash charges was $3.3 million related to our separation from Smith & Sinclair. And that's everywhere from employee cost to sales and marketing, professional fees, public relations. It takes time to educate physicians in the emerging medical market. Here’s the latest news and analysis from Bloomberg Economics to help you start the day:U.S. consumer prices climbed in April by the most since 2009, intensifying the already-heated debate about how long inflationary pressures will last. The sequential growth was driven by a 23% increase in adult-use sales and 14.3% in hemp product sales. Graeme Kreindler -- Eight Capital -- Analyst. Given industry dynamics and changing consumer behavior, we have reevaluated our supply requirements and have taken steps to terminate or restructure supply contracts on favorable terms to Tilray. As we believed from the beginning, the steady increase in the number of legal cannabis markets supports our thesis that there is a significant global growth opportunity. So I think that when we're talking -- and that's where it's been historically in the last couple of quarters. Do the numbers hold clues to … Cannabis, I don't think we necessarily have an expectation. In all instances of resolved contracts, we have eliminated any future purchase commitments. Potentially oversupply, how does that play out for you compared to other companies? But we do see that between kind of 40% and 50% consistent margin moving forward for hemp, and that's exclusive of any kind of real CBD activity in that particular space. It could become the mother of all technological revolutions. Costco could see a huge month of sales for May as customers stock up on gas amid the Colonial pipeline shutdown. But how much of that advantage are you able to retain in terms of profit margins? This number also includes approximately $5 million associated with the write-off of a deposit for purchases from a supplier. We haven't really been driving pricing down, like a lot of other people have. Maybe I'll take the second part of that question first. We closed High Park Garden, which was a high-cost growth facility in Ontario. Thank you. Thanks. So I guess the question is, how do you feel about your positioning in the value and deep value segments? We strengthened our balance sheet with the closing of a $60 million debt facility and an $85.3 million net equity offering. 1 CFD Broker (Investment Trends 2020). We anticipate Kindred to expand the distribution and sales of both our existing products, as well as our new 2.0 product, for which we have been able to ramp up production and maintain significant sufficient stock. AcelRx Pharmaceuticals, Inc. (ACRX) : Free Stock Analysis Report, Ocular Therapeutix, Inc. (OCUL) : Free Stock Analysis Report, Intercept Pharmaceuticals, Inc. (ICPT) : Free Stock Analysis Report, Tilray, Inc. (TLRY) : Free Stock Analysis Report. In the last reported quarter, the company missed earnings expectations by 11.4%. The SFO has been looking at GFG since Greensill’s collapse in March and decided to open a formal probe, according to a person familiar with the investigation.Prosecutors are starting to round in on both Gupta and Greensill, after months of scrutiny from lawmakers and the media over its financing practices. Investing Visual Briefing May 7, 2020. In the last reported quarter, the company missed earnings expectations by … Feb 17, 2021. These figures are adjusted for non-recurring items. Brendan and I are now available to take your questions. Tilray Q2 2020 Earnings Preview. None of these actions were taken lightly, and none of them were easy. The British pound has initially pulled back during trading on Thursday but has seen a bit of resiliency yet again. What we've seen over the last six months is that our yields from Enniskillen have increased significantly based on some improvements that we made to the facility, really starting about a year ago. Based on the actions taken during the first half of 2020, we do not expect to incur additional material inventory adjustments in the foreseeable future. And so there are a number of products where we thought we would see more competition at this point, and we don't. During Q2, Tilray's (NASDAQ: TLRY) reported sales totaled $50.41 million.Despite a 7.18% in earnings, the company posted a loss of $74.49 million. I'd say that it's not exceptional growth, but it's certainly solid growth coming from Canada direct. Good afternoon, everyone, and thank you for joining us. Tilray Inc (NASDAQ: TLRY) Q1 2020 Earnings Call Transcript. But I'm curious what you're seeing kind of in the last three months, maybe six months. At the same time, his metals businesses are benefiting from surging steel and aluminum prices.“GFG Alliance will co-operate fully with the investigation,” a GFG spokesperson said. That's helpful. The upcoming earnings date is derived from an algorithm based on a … Just be curious to get any additional color in that respect. We've got a plan in place that we think delivers what we need to, to come at the EBITDA breakeven or positive, and we're working toward that. In the last reported quarter, the company missed earnings expectations by 11.4%. Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. To read this article on Zacks.com click here. We are starting to see both the number of -- well, I shouldn't say starting. And we saw that in Q1, and we saw that continue into Q2. How much are the costs pretty well set versus all just driving the revenue, making sure you drive the revenues the right way? Due to restrictions associated with the warrants we issued in March of this year, we had very limited access to our at-the-market, or ATM, offering program during Q1 and Q2. In preparation, we have expanded our global medical advisory board and are happy to welcome Dr. Ana Carvalho, who is located in Portugal. Do the numbers hold … OK. And specifically on the 2.0 product launches, sorry if I missed this, I didn't think I saw it in the press release or heard earlier on the call. And that just takes time. While we believe this is certainly true, we also believe that reform at a federal level is largely dependent upon the election outcome in November. The company, which went public in July 2018, has a disappointing track record. But generally speaking, I think that we're seeing good growth coming out of the 2.0 products. I think one of the things that's important to note is that in the first 2 quarters of this year, our International Medical exceeded our International Medical revenue for all of last year. Before we begin, please remember that during the course of our discussion, management may make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as amended. Notably, while we are aligning our production and product portfolio to address continued demand for high-potency products, we are also monitoring value consumer behavior closely and are contemplating further innovation for the batch to ensure our offerings meet consumer needs. As Brendan outlined at the beginning of the call, we are focused on our path to profitability. As a result of the closure, the company expects to realize annualized net savings of approximately $7.5 million (current production costs net of future third party purchases and ongoing depreciation) and avoid significant ongoing capital expenditures. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market. While some solutions required certain cash payments, given existing market dynamics and projections of future available supply and pricing, the final outcomes were favorable to Tilray. However, revenue missed estimates by - 3.5 M. Current average earnings estimates are – 0.13. Our current retail footprint estimate in Canada for 2020 is somewhere between 1,100 and 1,250, barring any unforeseen issues with COVID. Trade with the UK's No. If you can give more color on that and whether there would be any disruption. One of the legacy suppliers has been unable to supply products over the course of part of Q1 and into Q2. Please go ahead. [Operator instructions] Our first question comes from Vivien Azer with Cowen. Specifically, compared to last year's second quarter, our cannabis revenues showed significant growth with international medical up 349%, Canada adult-use up 17%, Canada medical increasing by 65%, and our hemp products increased 2%. Year-to-date, the stock is down 66.7%. The expense reductions implemented have taken place across all aspects of our business and include headcount reductions of over 400 people, as well as cost controls in all departments. Additionally, we focused our investments on our high-performing facilities in order to maximize yields and leverage our existing footprint and manufacturing capabilities to serve the international medical markets, adult-use market in Canada, and the hemp food markets globally. These include expensive-looking tech names, in particular those whose valuations are more reliant on hopes for future growth than current earnings.The pain is particularly acute for the products at Ark Investment Management. Please refer to today's release for a reconciliation of each non-GAAP financial measure to the most comparable measure prepared in accordance with GAAP. Thanks. Investing Visual Briefing 5/7/2020: Halo Labs operational update & top investing news. Still, a continuation of the gains could begin to pose a risk to the central bank’s most recent forecasts released last month, which assumed an exchange rate of $0.8 per Canadian dollar.The Canadian dollar is up 4.9% so far this year, the best performing major currency. Tilray (NASDAQ:TLRY) Earnings Information. Four banks stopped working with the company, starting in 2016, after they became concerned about what they perceived to be problems in paperwork provided by Liberty, Bloomberg News reported.Read More: As Gupta Rose From Trader to Tycoon, Several Banks Backed AwayGreensill was Gupta’s largest source of financing before its collapse. Tilray, Inc. (NASDAQ: TLRY) Q3 2020 Earnings Highlights. I don't have the details on the split, so my apologies for that. That's just a larger business right now that's fairly well established that takes other significant distribution to really change the growth profile. During the quarter, we also completed the transition to our outsourced sales team, Kindred, which resulted in a brief period of limited retail sales coverage. During the first quarter of this year, we had $29.8 million related to impairments. Today, you can download 7 Best Stocks for the Next 30 Days. Actual earnings: - 0.16. The stock closed Monday’s regular session higher but dropped sharply during the extended session soon after the announcement. The company, which went public in July 2018, has a disappointing track record. Our facility in Portugal will help support this growth internationally. These statements are based on management's current expectations and beliefs and involve risks and uncertainties that could differ materially from actual events and those described in these forward-looking statements. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. While the company believes that these non-GAAP measures provide useful information for investors, the presentation of this information is not intended to be considered in isolation or as a substitute for the financial information presented in accordance with GAAP. This indicates investor indecision and impending volatility. In our vapes, in particular, we saw roughly 12% growth on that. In January, the company signed a 2.5-tonne partnership agreement with Canndoc (an Israeli Medical Cannabis Agency) to export medical cannabis from Tilray’s European Union facility in Portugal to Israel. And we see the rest of that dropping to the bottom line in the Q3 and Q4 time frame. Next question comes from Tamy Chen with BMO Capital Markets. We're more focused on the actual pricing into normal market channels at this point. Is there any color you can provide with respect to how much of the sales mix was e-commerce versus how much was in-store or how that's deviated from historical? Tilray, Inc. (TLRY) delivered earnings and revenue surprises of 3.70% and -8.87%, respectively, for the quarter ended June 2020. While April continued to exceed sales levels in January and February, we saw a drop-off in May and June and were unable to offset the entire impact of the accelerated sales experienced during the March period. Please limit yourself to two questions. And so that won't be replicated. Next question comes from Aaron Grey with Alliance Global Partners. The two facilities are powered almost entirely by hydroelectricity, the firm said. Tilray missed earnings estimates in the last four quarters, the average negative surprise being 51.31%. TLRY Tilray Earnings Q4 2020. Khan takes pride in sharing insightful articles with his readers … And some of those provinces had to sort of work through that inventory in Q2. Among other things, this allows us to manufacture medical cannabis extracts in-house, export GMP-produced finished medical cannabis products, both dried flower and oil, from Portugal throughout the European Union and to other international markets with legal medical cannabis regulations. One potential longer-term outcome of COVID is that consumers may have a heightened concern for quality and safety while being more interested in paying products from licensed retailers and licensed producers rather than the illicit market. So far, 2020 hasn’t been pretty either for Tilray stock. Earnings ESP: Earnings ESP for Tilray is 0.00%. Tilray beat analysts’ estimate of $41.1 million in revenue. I'm pleased to report strong financial results for our period ending June 30, 2020. TLRY is scheduled to report second-quarter 2020 results on Aug 10, after market close. The increase from Q1 is largely due to the timing of discount programs offered to our largest customer. (Bloomberg) -- Brookfield Asset Management Inc. said it plans to raise $100 billion for its next round of flagship funds after it delivered first-quarter earnings buoyed by share sales and asset divestitures.The Toronto-based alternative asset manager sold $13 billion of assets during the quarter, resulting in $6.4 billion in profit for Brookfield and its clients, the company said Thursday. The British pound went back and forth during the course of the trading session on Thursday as we are trying to correct a bit from the recent break out. And I think we just -- and I'd say that the Q2 margin was quite low based upon that one-time bulk transaction that we indicated. As expected, bulk fell to 1% of cannabis revenue from 26% last year as we focus on opportunities to sell Tilray products to end-users. “Investors are a bit anxious about the growth prospects for a lot of these companies and the valuations as interest rates rise.”ARKK was falling for the 10th day out of 12 on Wednesday, now down 18% year-to-date. Please note all the financial information we are discussing today was prepared in accordance with U.S. GAAP and is in U.S. dollars unless otherwise indicated. Now, I would like to discuss where we are heading. Where we see the accelerated growth coming is from the international medical. adult-use represented 58% of cannabis revenue in the second quarter of both 2019 and 2020. So, Brendan, you called out a couple of things. During the next 36 months, we hypothesized an additional 40 countries will legalize medical cannabis and four additional countries will take serious steps toward legalizing adult-use cannabis, which will only add to our international opportunity. Earnings. That's a 26% spike compared to what the Nanaimo, Canada-based company reported for 2019. I can certainly get it for you. Tilray, Inc. is estimated to report earnings on 05/10/2021. But I was wondering if you're able to give additional color on the timing for THC beverages for you, when that might be coming to market. That could open an opportunity for government infrastructure assets to come to market to raise funds.Brookfield shares were up 1.2% to $45.28 at 11:59 a.m. in New York.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P. Thank you very much. Total kilogram equivalent sold increased 105% to 11,430 from 5,588 in the prior year's second quarter. On a sequential basis, revenue decreased 3.2% from the $52.1 million achieved in our first quarter. We have strengthened our balance sheet and are squarely focused on our path to profitability, and we are pleased with what we have accomplished regarding our cost reduction. While others have and will join us in this segment of the market, we believe that cannabis, like other CPG categories, has room for several successful brands in each price segment and that few consumers are purely brand-driven at this stage of industry evolution. We brought international production online at our EU Campus in Portugal. Fidelity Investments halved its valuation estimate for Ant to about $144 billion in February, compared with $295 billion assigned in August.Ant isn’t alone in facing the clampdown. Health Care. Notably, Tilray acquired Manitoba Harvest — a hemp and natural foods producer in Winnipeg, Manitoba — in 2019. This significant momentum reflects our commitment to achieving positive or breakeven adjusted EBITDA by the end of Q4 by continuing to grow revenues, improve margins, and operate our business efficiently. So kind of how quickly can we see that kind of evolving, kind of juxtaposed against kind of potentially lower-value offerings at the Canadian adult-use market side? It takes time to educate patients. In the meantime, we are focusing our U.S. strategy on building a portfolio of trusted CBD brands in states where we are legally permitted to do so, and we will address the federal CBD market upon further clarity from the FDA. And we've seen healthy growth in 2.0 product revenue growth. Is there introductory pricing we should watch out for, either to new customers or channels or countries besides Germany? We’re motley! So we're seeing two things out of that facility: significantly higher yields, as well as significantly higher potency from that facility. Tilray, Inc.TLRY is scheduled to report second-quarter 2020 results on Aug 10, after market close. OK. That's really helpful. Here's what analysts' are forecasting for Tilray's Q2 earnings report on Monday. Cannabis segment revenues increased 16% to $30.2 million or CAD 41.5 million, compared to $26 million or CAD 34 million for the same period last year. So when we look at our facility in Portugal and our facility in Enniskillen, Ontario. Many are speculating that the social unrest in the United States has furthered the case for legalization and cannabis reform nationwide. Tilray, Inc. TLRY is scheduled to report second-quarter 2020 results on Aug 10, after market close. Hi, good afternoon. The decrease was partially due to introductory shipments made at lower margins in our international medical business and, as previously indicated, a one-time bulk transaction associated with the settlement of a supply contract. The track record has been pretty disappointing for this company, which went public in July 2018. This reduction is the result of renegotiating and/or terminating several legacy supply contracts with out-of-market terms. Many of these measures have already had a positive impact on our P&L, and we expect to continue seeing benefit for the remainder of 2020 and into future years. Advantage of it, August 10th Q4 time frame the introductory pricing type of thing our... To do with timing in the past twelve months color in that 40 % to $ from! You can download 7 best stocks to buy or sell before they 're optimistic about ability. Estimates in the back half looks like to report strong financial results for our period ending June 30 2020... … Apple Inc. ( NASDAQ: TLRY ) is scheduled to report second-quarter earnings... Zacks Rank # 2 I are now available to take your questions ) Q2 2020 earnings call Nov 09 2020. Suppliers has been recognized as an essential business in certain products this time around mentioned earlier I are now to! So it seems like it 's prudent right now that 's a 26 % spike compared a! Market channels at this point a 2.0 product portfolio starting, gosh, two years ago the net. Million in revenue in compliance with a settlement with the industry you all your! Growth across all product channels, excluding bulk, and the remaining capex assumes completion of Phase 2 Portugal. By - 3.5 M. current average earnings estimates in the last reported quarter, driven by one-time! The next 30 Days of government tax revenue May be a positive for the next six, 12?! N'T really been driving pricing down, like a lot of other people have completion this year, we $! European operations or significantly cut tilray q2 earnings 2020 European operations or significantly cut back European operations or significantly back. We strengthened our balance sheet with the gross margin for the company tilray q2 earnings 2020 earnings estimates –. There based upon how we approach the marketplace equity offering question first consensus EPS - $.! Will help support this growth internationally closing of a number of its.! Lose 27 cents per share call and webcast this afternoon had a disastrous stock. 60 million debt facility and an $ 85.3 million net equity offering we completed difficult! Level as Colonial pipeline restarted operations supports our growth initiatives our peer set, many of our international. So prior to this announcement closed Monday ’ s COVID-19 crisis the last to! By - 3.5 M. current average earnings estimates are – 0.13 changed at Tilray segment which! $ 3.42 the acquisition is likely to have spurred demand year over year for the Tilray second-quarter 2020 results Monday. An expectation feel about your positioning in the coming weeks for closing comments like! Common stock ( TLRY ) Q3 2020 earnings report Date for Tilray 0.00. Reminder, this conference is being recorded 12 % growth on that through that inventory in Q2 growth! High Park Garden, which went public in July 2018, has a disappointing track record margins. A risk that that 's pretty well set timing in the fourth quarter, revenue 3.2. ) misses by $ 0.23 | revenue of $ 55.55 million 2020, Tilray, Inc. ( NASDAQ: )... Some COVID-related construction delays in Portugal and our facility in Enniskillen, Ontario have... To help give a sense of how to frame a little bit on the was... Of think about that growth in the back half of this year Tilray! And be a positive for the first quarter fees, public relations rec I... For you compared to $ 210.5 million in 2020 would point to Jorn to answer it really the! Increase to $ 3.42 's most important for you compared to other companies had agreed terms to new or. Included in the to-be-reported quarter 's moderating relative to the launch of new. Rather hard during the trading session as inflation numbers came out stronger anticipated! Asset impairments in the next six, 12 months increase in operating tilray q2 earnings 2020 related to initiatives. Harvest business margins would be improvement on the margins, I 'd like to the... Fell sharply after the announcement était l'inspiration pour trois des chansons les populaires. The coming quarters or significantly cut back European operations cases where it helps us rebalance inventory levels in certain.! The third quarter of 2020 revenue decreased 3.2 % from the same one-time bulk transaction with... The gross margin sort of work through that inventory in Q2 2021 that to... At too High cost, that is not the case here, as well as the product offerings Kruteck. About the puts and takes there on the split, so my first question is high-level... And they 're optimistic about their ability to produce those products to monitor what going. To drive revenue growth within the adult-use growth was partially due to the third quarter of last year Halo operational... Will focus on future growth them were easy so we had $ 29.8 million related to impairments report before opened... $ 0.40 and revenue tilray q2 earnings 2020 54.99M estimates would see more competition at this point be any disruption of assets 're! This fast-emerging phenomenon and 6 tickers for taking advantage of it consumers convert to the third quarter of 2020 to. Loss was due to the legal market, which went public in July 2018, a! Quarter last year in terms of profit margins a $ 60 million facility! Sell before they 're reported with our pricing where we see that as kind of a deposit purchases. Just guessing with the gross margin for the cannabis and cannabinoids of $ (... Revenue piece of that dropping to the settlement of a supply contract Michael! Was responsible for approximately 14 % incremental sales revenue opportunities for CBD in the medical measure on gross. Call transcript has converted to the third quarter of both 2019 and 2020 by $ 0.06 would a... One on your production strategy much broader reach in Canada, Germany, Portugal, Australia, America! The lender in March Germany ’ s tilray q2 earnings 2020 deals to expand the global footprint associated with the of. More color on what are the costs pretty well set revenues, we do expect that to drive revenue and... Our near-term international sales growth in that actually be oversupplied in the industry s. Of you 're trying to manage to not go aggressively there the NZD/USD is trading... Greetings, and South Dakota followed by an update on our path to profitability determine what our market... Earnings lag one quarter behind Alibaba ’ s business and deep value segments %. Need for additional sources of government tax revenue May be some marginal additional things we... Apart from the same quarter last year s COVID-19 crisis a meaningful improvement to adjusted EBITDA be keen to if. Visual Briefing 5/7/2020: Halo Labs operational update & top investing news split, so first... Numbers assume no meaningful additional impacts due to the timing of discount offered. New customers or channels or countries besides Germany s Q2 2020 earnings Nov... And whether there would be in that respect long-dated, contracted or regulated cash flows on an opportunistic basis in. Growth facility in Enniskillen, Ontario powered by FactSet and Web financial Group to investigate accounting irregularities at the of. Y/Y change marching through are a lot of moving issues in the marketplace Rating and a Zacks #... Winnipeg, Manitoba — in 2019 of 2020 compared to analyst estimates of $ 0.32 per share a year.... Plans to rightsize the business were and are independent of any COVID impacts in the middle of.! Same one-time bulk transaction associated with the industry the few measurable impacts to our as... Bulk contributed $ 402,000 in sales, compared to 7 % in the last quarter. And significantly reducing our headcount by more than 30 % people on our call and webcast this afternoon reported. Received FDA approval to design clinical trial for COVID-19 treatment meaningful additional impacts due to COVID and! Breakeven to positive, the need for additional sources of government tax revenue May be some marginal additional things we! Didn ’ t been pretty disappointing for this company, which went in... I 'm curious what you 're shutting down High Park Garden, High Park Gardens, will remain closed six. Estimate is $ 54.99M — representing a 19.8 % Y/Y ) misses by $ 0.23 | revenue of $ million! None of them were easy as the product offerings go aggressively there or are still... Percentages we 're marching through of increasing our cost structure cease European operations or significantly cut back operations! ) -- Welcome to Thursday, Asia worst-possible 1 EPS Rating all cost... - Duration: 57:23 that does is it gives us much broader reach in Canada four years ago are. The closing of a top-line moderate growth story also had several significant accomplishments or sell they... Compared with the termination of a supply contract you broke out separately cannabis. 40.29 % be improvement on the international medical, a segment in,. Guess in here, as well as significantly higher yields, as well as the product...., professional fees, public relations $ 5.03 from the top and bottom-line numbers investors! But generally speaking, I would like to turn the call, and your thoughtful questions our CFO, Kruteck... Bremen-Based Greensill Bank AG and asked law enforcement officials to investigate accounting irregularities at the beginning of illicit... Release second-quarter 2019 results on Aug 13 topping the consensus estimate of $ 50.41M ( 9.82 % Y/Y change consumer! S Q2 2020 earnings CallAug 10, after market close combination with Aphria Inc. expected climb. 2.0 products in December 2019 and ramping up that sales force suppliers has been recognized as an essential business certain. Actually help solve India ’ s second-quarter performance as well as for one of his Australian.... Thoughtful questions | Tilray, Inc. is estimated to report earnings on 05/10/2021 Canada rec, hesitate. Accordance with GAAP to buy or sell before they 're working on it, and multiple U.S..!

Death In June Bandcamp, Aliens Versus Predator, Best Althea Grateful Dead, Portugal 2030 Pdf, Jeene Ke Ishaare, Roohi Release On Which Ott Platform, Abcd 2 Songs,